One interesting fact: most medical colleges and linked public hospitals in major cities were designed in the British era, with an open ward design. A medical administrator, tongue-in-cheek, put it succinctly: “When these hospitals were designed, nobody would have imagined that doctors will face violence”. Time for design thinking in public healthcare delivery!

KKR's Investments in India's Medical Devices Market: Strategic Implications...

2020 has been a challenging year for all industries. For pharma and its HCP customers even more so. All eyes are on the companies developing vaccines and drugs for treatment of COVID-19, while doctors have closed their doors for pharma reps. Long established processes have been disrupted and complex market strategies have been rendered useless. Each pharma no matter big or small, innovative, or generic, had to improvise and come up with contingency plans to save the year. Some have been slower waiting for the old ways to come back, others have been more agile experimenting with digital and expanding boundaries, most are in the middle digitally curious but not risking too much.

The digital revolution is the fourth industrial revolution. It changes models, processes and whole public sectors. In many reports you will find that, in terms of digitalization, pharma is just next to the public sector, as least digitalized. Pharma just started late. There are many reasons for that – it is one of the most regulated industries with lots of sensitive data involved and many ethical aspects. But the slowed down digitalization has a lot to do with some subjective reasons. Adopting digital technologies requires changing existing models which requires a different mindset – and this is difficult to achieve. Nowadays, in the situation of a global pandemic, we see that digital communication is not only necessary to be successful but it is a must in order to adapt to the New Normality.

Overall IPM Performance: Monthly Growth: IPM monthly growth reached 8.4% in...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...

The Indian Pharmaceutical Market (IPM) maintained moderate growth in...

The future in your palm - a non-contact wearable...

Nimesulide Regulatory Status Worldwide Nimesulide is a non-steroidal anti-inflammatory drug...

Indian Pharma Top Brands, Therapy & Regional Insights 🏆...

April 14, 2025  India’s pharmaceutical industry, a global powerhouse, sends...